Provided by Tiger Trade Technology Pte. Ltd.

Quanterix Corp

6.17
+0.08001.31%
Post-market: 6.170.00000.00%17:41 EST
Volume:468.37K
Turnover:2.86M
Market Cap:288.21M
PE:-2.62
High:6.23
Open:6.06
Low:5.80
Close:6.09
52wk High:8.77
52wk Low:4.05
Shares:46.71M
Float Shares:37.82M
Volume Ratio:0.67
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3579
EPS(LYR):-1.0043
ROE:-29.28%
ROA:-11.28%
PB:0.92
PE(LYR):-6.14

Loading ...

Quanterix Submits FDA 510(k) Application for Multi-Analyte Blood Test for Alzheimer's Detection

Reuters
·
Feb 03

Quanterix Announces FDA 510(K) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer’s Disease Detection

THOMSON REUTERS
·
Feb 03

Frontage Europe Relocates Bioanalytical Laboratory Near Milan

Reuters
·
Jan 28

Quanterix Corporation Files Initial Statement of Beneficial Ownership for President and CEO Everett Cunningham

Reuters
·
Jan 22

Quanterix Unveils Landmark Study Showing Multi-Biomarker Blood Test Improves Early Alzheimer’s Risk Profiling

Reuters
·
Jan 21

Quanterix Grants Equity Awards to New Employees Under Inducement Plan

Reuters
·
Jan 17

Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January

Benzinga
·
Jan 10

BRIEF-Quanterix Appoints Everett Cunningham As President And CEO Effective January 19, 2026

Reuters
·
Jan 09

Quanterix names Everett Cunningham president, CEO

TIPRANKS
·
Jan 09

Quanterix Names Everett Cunningham as President and CEO

Reuters
·
Jan 09

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

THOMSON REUTERS
·
Jan 09

Quanterix Corp - Masoud Toloue to Continue as CEO Until January 2026

THOMSON REUTERS
·
Jan 09

Quanterix Corp: Expects to Exceed Revenue and Cash Guidance for Full Year 2025

THOMSON REUTERS
·
Jan 09

Analysts Offer Insights on Healthcare Companies: Quanterix (QTRX), Indivior (INDV) and GeneDx Holdings (WGS)

TIPRANKS
·
Jan 08

Quanterix Study Finds 30% of Seniors Show Alzheimer’s Pathology Using Blood Test

Reuters
·
Dec 22, 2025

Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence

THOMSON REUTERS
·
Dec 22, 2025

Quanterix Corporation Files Initial Statement of Beneficial Ownership for Director Alan Bruce Sachs

Reuters
·
Dec 08, 2025

Quanterix Corporation Files Initial Statement of Beneficial Ownership for Director Malcolm Garret Hampton

Reuters
·
Nov 26, 2025

Quanterix Appoints New Board Members and Executive Chair

Reuters
·
Nov 21, 2025

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

THOMSON REUTERS
·
Nov 21, 2025